×
返回 Agenda
Session 4: The IND in Detail - Modules 4, 5, and 2
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- IND Item 8: Nonclinical Pharmacology and Toxicology
- IND Item 9: Previous Human Experience
- IND Item 10: Additional Information